Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells

被引:21
|
作者
Long, Joseph [1 ,2 ]
Hoban, Megan D. [1 ]
Cooper, Aaron R. [3 ]
Kaufman, Michael L. [1 ]
Kuo, Caroline Y. [4 ]
Campo-Fernandez, Beatriz [1 ]
Lumaquin, Dianne [1 ]
Hollis, Roger P. [1 ]
Wang, Xiaoyan [5 ]
Kohn, Donald B. [1 ,6 ]
Romero, Zulema [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3146 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA
[2] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA
[3] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy & Immunol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA
关键词
ZINC-FINGER NUCLEASES; SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELLS; RETROVIRAL VECTOR; BCL11A KNOCKDOWN; COPY NUMBER; DISEASE; THERAPY; CRISPR-CAS9; THALASSEMIA;
D O I
10.1016/j.ymthe.2017.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of engineered nucleases combined with a homologous DNA donor template can result in targeted gene correction of the sickle cell disease mutation in hematopoietic stem and progenitor cells. However, because of the high homology between the adjacent human beta- and delta-globin genes, off-target cleavage is observed at delta-globin when using some endonucleases targeted to the sickle mutation in beta-globin. Introduction of multiple double-stranded breaks by endonucleases has the potential to induce intergenic alterations. Using a novel droplet digital PCR assay and high-throughput sequencing, we characterized the frequency of rearrangements between the beta- and delta-globin paralogs when delivering these nucleases. Pooled CD34(+) cells and colony-forming units from sickle bone marrow were treated with nuclease only or including a donor template and then analyzed for potential gene rearrangements. It was observed that, in pooled CD34(+) cells and colony-forming units, the intergenic beta-delta-globin deletion was the most frequent rearrangement, followed by inversion of the intergenic fragment, with the inter-chromosomal translocation as the least frequent. No rearrangements were observed when endonuclease activity was restricted to on-target beta-globin cleavage. These findings demonstrate the need to develop site-specific endonucleases with high specificity to avoid unwanted gene alterations.
引用
收藏
页码:468 / 479
页数:12
相关论文
共 50 条
  • [21] Efficient Nanoparticle-Mediated Delivery of Gene Editing Reagents into Human Hematopoietic Stem and Progenitor Cells
    El Kharrag, Rkia
    Berckmuller, Kurt
    Cui, Margaret
    Madhu, Ravishankar
    Perez, Anai M.
    Humbert, Olivier
    Kiem, Hans-Peter
    Radtke, Stefan
    BLOOD, 2021, 138
  • [22] The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV
    Karuppusamy, Karthik, V
    Babu, Prathibha
    Thangavel, Saravanabhavan
    STEM CELL REVIEWS AND REPORTS, 2021, 17 (05) : 1607 - 1618
  • [23] Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair
    Lomova, Anastasia
    Clark, Danielle N.
    Campo-Fernandez, Beatriz
    Flores-Bjurstrom, Carmen
    Kaufman, Michael L.
    Fitz-Gibbon, Sorel
    Wang, Xiaoyan
    Miyahira, Eric Y.
    Brown, Devin
    DeWitt, Mark A.
    Corn, Jacob E.
    Hollis, Roger P.
    Romero, Zulema
    Kohn, Donald B.
    STEM CELLS, 2019, 37 (02) : 284 - 294
  • [24] Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells
    De Ravin, Suk See
    Brault, Julie
    Meis, Ronald J.
    Liu, Siyuan
    Li, Linhong
    Pavel-Dinu, Mara
    Lazzarotto, Cicera R.
    Liu, Taylor
    Koontz, Sherry M.
    Choi, Uimook
    Sweeney, Colin L.
    Theobald, Narda
    Lee, GaHyun
    Clark, Aaron B.
    Burkett, Sandra S.
    Kleinstiver, Benjamin P.
    Porteus, Matthew H.
    Tsai, Shengdar
    Kuhns, Douglas B.
    Dahl, Gary A.
    Headey, Stephen
    Wu, Xiaolin
    Malech, Harry L.
    BLOOD, 2021, 137 (19) : 2598 - 2608
  • [25] Modelling Congenital Dyserythropoietic Anemia Type II through Gene Editing in Hematopoietic Stem and Progenitor Cells
    Dessy-Rodriguez, Mercedes
    Fananas-Baquero, Sara
    Venturi, Veronica
    Payan-Pernia, Salvador
    Tornador, Cristian
    Hernandez, Gonzalo
    Sanchez, Mayka
    Segovia, Jose C.
    Bustamante, Oscar Quintana
    BLOOD, 2020, 136
  • [26] The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV
    Karthik V Karuppusamy
    Prathibha Babu
    Saravanabhavan Thangavel
    Stem Cell Reviews and Reports, 2021, 17 : 1607 - 1618
  • [27] Gene Editing for Congenital Dyserythropoietic Anemia Type II Model in Human Hematopoietic Stem and Progenitor Cells
    Dessy-Rodriguez, Mercedes
    Fananas-Baquero, Sara
    Venturi, Veronica
    Payan, Salvador
    Tornador, Cristian
    Hernandez, Gonzalo
    Sanchez Fernandez, Mayka
    Bueren, Juan A.
    Carlos Segovia, Jose
    Quintana-Bustamante, Oscar
    MOLECULAR THERAPY, 2021, 29 (04) : 341 - 341
  • [28] Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
    Manoj Kumar K. Azhagiri
    Prathibha Babu
    Vigneshwaran Venkatesan
    Saravanabhavan Thangavel
    Stem Cell Research & Therapy, 12
  • [29] Homology-directed gene-editing approaches for hematopoietic stem and progenitor cell gene therapy
    Azhagiri, Manoj Kumar K.
    Babu, Prathibha
    Venkatesan, Vigneshwaran
    Thangavel, Saravanabhavan
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [30] Retroviral β-globin gene transfer into murine hematopoietic stem cells.
    Atweh, GF
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (05) : 491 - 491